Literature DB >> 32055957

Efficacy and safety of delivery of topical medication on to the frontal sinus at different head positions after frontal sinusotomy.

Yu-Xiao Wu1, Min Wang2, Hui Li1, Zhi-Min Xing1, Mu-Han Shi1, Shi-En Huang1, Yan Liu1, Cong-Li Geng1.   

Abstract

PURPOSE: Effective topical medications delivery to the frontal sinus is crucial to recovery from frontal sinusotomy. However, finding a way to deliver local medications to the frontal sinus is still a major challenge. The objective of this study was to evaluate the influence of various head positions on postoperative frontal sinus drug deposition. The safety and efficacy were also evaluated in postoperative chronic rhinosinusitis (CRS) patients.
METHODS: Full house surgery was performed on six fresh frozen cadaver heads. The fluorescein solution was dropped into the nasal sinuses in three different head positions, and the fluorescein deposition was evaluated. A prospective cohort study was performed to validate the results in 20 postoperative CRS patients. The cortisol level, symptom VAS and the frontal recess endoscopy scores were evaluated pre- and postoperatively.
RESULTS: The frontal recess delivery of fluorescein was better in the Mygind and vertex-to-floor positions than in the head back position. The cortisol level of patients dropped markedly after taking oral methylprednisolone, but returned to baseline when replaced with budesonide drops. The pre- and postoperative symptom VAS scores did not differ significantly between the two groups. Endoscopic scores of the vertex-to-floor group were significantly better than those of the Mygind group.
CONCLUSION: Both the Mygind and the vertex-to-floor head positions were optimal for delivery of topical medications to the frontal recess. When applying the steroid drops, both positions were found to be safe and associated with effective relief of symptoms. The vertex-to-floor position can better improve the endoscopic scores of frontal recess and frontal sinus.

Entities:  

Keywords:  Application of steroids; CRS (chronic rhinosinusitis); Deposition; Frontal recess; Frontal sinus; Head position

Mesh:

Substances:

Year:  2020        PMID: 32055957     DOI: 10.1007/s00405-020-05851-w

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

1.  The effect of head position on the distribution of drops within the nose.

Authors:  H Kubba; E Spinou; A Robertson
Journal:  Am J Rhinol       Date:  2000 Mar-Apr

2.  Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery.

Authors:  Albertien A C Aukema; Paul G H Mulder; Wytske J Fokkens
Journal:  J Allergy Clin Immunol       Date:  2005-05       Impact factor: 10.793

3.  Topical steroid drops for the treatment of sinus ostia stenosis in the postoperative period.

Authors:  John M DelGaudio; Sarah K Wise
Journal:  Am J Rhinol       Date:  2006 Nov-Dec

4.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

Authors:  Wytske J Fokkens; Valerie J Lund; Joachim Mullol; Claus Bachert; Isam Alobid; Fuad Baroody; Noam Cohen; Anders Cervin; Richard Douglas; Philippe Gevaert; Christos Georgalas; Herman Goossens; Richard Harvey; Peter Hellings; Claire Hopkins; Nick Jones; Guy Joos; Livije Kalogjera; Bob Kern; Marek Kowalski; David Price; Herbert Riechelmann; Rodney Schlosser; Brent Senior; Mike Thomas; Elina Toskala; Richard Voegels; De Yun Wang; Peter John Wormald
Journal:  Rhinology       Date:  2012-03       Impact factor: 3.681

5.  Endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps: Clinical outcome and predictive factors of recurrence.

Authors:  Rafaela Veloso-Teles; Rui Cerejeira
Journal:  Am J Rhinol Allergy       Date:  2017-01-01       Impact factor: 2.467

6.  Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps.

Authors:  Chengshuo Wang; Hongfei Lou; Xiangdong Wang; Yang Wang; Erzhong Fan; Ying Li; Hong Wang; Claus Bachert; Luo Zhang
Journal:  J Allergy Clin Immunol       Date:  2014-12-04       Impact factor: 10.793

Review 7.  Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits.

Authors:  Joaquim Mullol; Andrés Obando; Laura Pujols; Isam Alobid
Journal:  Immunol Allergy Clin North Am       Date:  2009-11       Impact factor: 3.479

8.  The effect of head position on the distribution of topical nasal medication using the Mucosal Atomization Device: a cadaver study.

Authors:  Al-Rahim R Habib; Andrew Thamboo; Jamil Manji; Rachelle C Dar Santos; Eng Cern Gan; Amy Anstead; Amin R Javer
Journal:  Int Forum Allergy Rhinol       Date:  2013-09-16       Impact factor: 3.858

9.  Endoscopically guided frontal sinus beclomethasone instillation for refractory frontal sinus/recess mucosal edema and polyposis.

Authors:  M J Citardi; F A Kuhn
Journal:  Am J Rhinol       Date:  1998 May-Jun

10.  Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities.

Authors:  J B Shi; Q L Fu; H Zhang; L Cheng; Y J Wang; D D Zhu; W Lv; S X Liu; P Z Li; C Q Ou; G Xu
Journal:  Allergy       Date:  2015-03-04       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.